Polycyclic indanylimidazoles with alpha2 adrenergic activity
US6362211B1 · kind B1 · utility
0Cited by
1References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 7, 2001 |
| Grant date | Mar 26, 2002 |
| Priority date | — |
| Expiry date | May 7, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D233/64
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of formula I wherein R1 to R3, —A—, m and t are as defined in claim 1, or a pharmaceutically acceptable salt or ester thereof, useful as an alpha2 adrenergic agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.